SCIESCOPUSQ1
Med
CELL PRESS, United States
Med is an academic journal published by CELL PRESS (United States). Identifiers: ISSN 2666-6359, eISSN 2666-6340. Indexed in SCIE, SCOPUS. Metrics: JIF 11.8, CiteScore 17.2, SJR 3.815, SNIP 1.39. Subject areas: MEDICINE, RESEARCH & EXPERIMENTAL. tlooto lists 933 papers from this journal.
CiteScore
17.20
Scopus citation metric
SJR
3.815
SCImago rank
SNIP
1.39
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2666-6359
- eISSN
- 2666-6340
- Abbreviation
- MED-CAMBRIDGE
- Publisher
- CELL PRESS
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2700 General Medicine
Papers in this journal
Recent papers
- Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis.
2026
- Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma.
2026
- Depression, cognition, and GLP-1 receptors: Heterogeneity and therapeutic prospects.
2026
- Coagulation factor XI and cardiovascular disease: A complex, cardio-specific conundrum.
2026 · 1 citations
- Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy.
2026 · 1 citations
Most cited papers
- Machine learning in clinical decision making.
2021 · 208 citations
- Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease.
2024 · 196 citations
- Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects.
2022 · 186 citations
- Promises and Challenges of Organoid-Guided Precision Medicine
2021 · 152 citations
- CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.
2024 · 145 citations